IL90191A0 - 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents
3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the sameInfo
- Publication number
- IL90191A0 IL90191A0 IL90191A IL9019189A IL90191A0 IL 90191 A0 IL90191 A0 IL 90191A0 IL 90191 A IL90191 A IL 90191A IL 9019189 A IL9019189 A IL 9019189A IL 90191 A0 IL90191 A0 IL 90191A0
- Authority
- IL
- Israel
- Prior art keywords
- pyrrolidinylthio
- azabicyclo
- hept
- ene
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888811237A GB8811237D0 (en) | 1988-05-12 | 1988-05-12 | 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
IL90191A0 true IL90191A0 (en) | 1989-12-15 |
Family
ID=10636779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL90191A IL90191A0 (en) | 1988-05-12 | 1989-05-04 | 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
Country Status (16)
Country | Link |
---|---|
US (1) | US4983596A (no) |
EP (1) | EP0341557A1 (no) |
JP (1) | JPH02204490A (no) |
CN (1) | CN1038645A (no) |
AU (1) | AU3402289A (no) |
DK (1) | DK230689A (no) |
FI (1) | FI892281A (no) |
GB (1) | GB8811237D0 (no) |
HU (1) | HU208013B (no) |
IL (1) | IL90191A0 (no) |
MX (1) | MX15990A (no) |
NO (1) | NO168825C (no) |
NZ (1) | NZ229071A (no) |
OA (1) | OA09419A (no) |
PT (1) | PT90527A (no) |
ZA (1) | ZA893479B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8923844D0 (en) * | 1989-10-23 | 1989-12-13 | Fujisawa Pharmaceutical Co | Carbapenem compounds |
GB9103034D0 (en) * | 1991-02-13 | 1991-03-27 | Fujisawa Pharmaceutical Co | Processes for preparing carbapenem derivatives |
US5360798A (en) * | 1991-07-04 | 1994-11-01 | Shionogi Seiyaku Kabushiki Kaisha | Aminooxypyrrolidinylthiocarbapenem compounds |
US5608056A (en) * | 1992-04-13 | 1997-03-04 | Fujisawa Pharmaceutical Co., Ltd. | Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552873A (en) * | 1981-08-19 | 1985-11-12 | Sankyo Company Limited | Carbapenem compounds, and compositions containing them |
JPS5916892A (ja) * | 1982-07-19 | 1984-01-28 | Sankyo Co Ltd | カルバペネム−3−カルボン酸誘導体およびその製法 |
KR900006449B1 (ko) * | 1982-08-24 | 1990-08-31 | 상꾜 가부시끼가이샤 | 아제티디논 화합물의 제조방법 |
CA1283906C (en) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF |
JPS60202886A (ja) * | 1984-03-27 | 1985-10-14 | Sankyo Co Ltd | 1―置換カルバペネム―3―カルボン酸誘導体 |
EP0182213B1 (en) * | 1984-11-08 | 1990-09-26 | Sumitomo Pharmaceuticals Company, Limited | Carbapenem compounds and production thereof |
EP0243686B1 (en) * | 1986-03-27 | 1992-07-15 | Sumitomo Pharmaceuticals Company, Limited | Beta-lactam compounds, and their production |
KR880006244A (ko) * | 1986-11-24 | 1988-07-22 | 후지사와 도모 기찌 로 | 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법 |
-
1988
- 1988-05-12 GB GB888811237A patent/GB8811237D0/en active Pending
-
1989
- 1989-05-03 EP EP89107967A patent/EP0341557A1/en not_active Withdrawn
- 1989-05-04 IL IL90191A patent/IL90191A0/xx unknown
- 1989-05-04 AU AU34022/89A patent/AU3402289A/en not_active Abandoned
- 1989-05-04 US US07/347,025 patent/US4983596A/en not_active Expired - Fee Related
- 1989-05-10 MX MX1599089A patent/MX15990A/es unknown
- 1989-05-10 NZ NZ229071A patent/NZ229071A/en unknown
- 1989-05-10 ZA ZA893479A patent/ZA893479B/xx unknown
- 1989-05-11 HU HU892369A patent/HU208013B/hu not_active IP Right Cessation
- 1989-05-11 PT PT90527A patent/PT90527A/pt not_active Application Discontinuation
- 1989-05-11 DK DK230689A patent/DK230689A/da not_active Application Discontinuation
- 1989-05-11 FI FI892281A patent/FI892281A/fi not_active Application Discontinuation
- 1989-05-11 NO NO891919A patent/NO168825C/no unknown
- 1989-05-12 JP JP1119141A patent/JPH02204490A/ja active Pending
- 1989-05-12 OA OA59575A patent/OA09419A/xx unknown
- 1989-05-12 CN CN89103171A patent/CN1038645A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
DK230689A (da) | 1989-11-13 |
NO168825B (no) | 1991-12-30 |
EP0341557A1 (en) | 1989-11-15 |
OA09419A (fr) | 1992-10-15 |
CN1038645A (zh) | 1990-01-10 |
GB8811237D0 (en) | 1988-06-15 |
NO891919D0 (no) | 1989-05-11 |
FI892281A0 (fi) | 1989-05-11 |
MX15990A (es) | 1993-09-01 |
AU3402289A (en) | 1989-11-16 |
PT90527A (pt) | 1989-11-30 |
NZ229071A (en) | 1990-08-28 |
NO891919L (no) | 1989-11-13 |
NO168825C (no) | 1992-04-08 |
DK230689D0 (da) | 1989-05-11 |
US4983596A (en) | 1991-01-08 |
FI892281A (fi) | 1989-11-13 |
HU208013B (en) | 1993-07-28 |
ZA893479B (en) | 1990-01-31 |
HUT50476A (en) | 1990-02-28 |
JPH02204490A (ja) | 1990-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL84446A0 (en) | 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL100899A0 (en) | Beta-amino-alpha-hydroxycarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL91360A0 (en) | Cyclodextrin derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL96019A0 (en) | Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL86782A0 (en) | Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions comprising the same | |
IL87116A0 (en) | 9-halogen-(z)-prostaglandin derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
AU7227587A (en) | Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
IL83467A0 (en) | Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same | |
IL112193A0 (en) | Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL87731A0 (en) | Cephem derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL87809A0 (en) | Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
DE3374686D1 (en) | 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | |
AU2974189A (en) | Pharmaceutical compositions containing lactams, new substituted lactams and processes for the preparation thereof | |
IL80160A (en) | Beta-lactam derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
AU8245087A (en) | New pyrrolobenzimidazoles, processes for the preparation thereof and pharmaceutical compositions containing them | |
IL105348A0 (en) | Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL92425A0 (en) | Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof | |
AU1122688A (en) | Substituted 3,4-dihydro-2h-benzopyrans, processes for their preparation, their use and pharmaceutical products based on these compounds | |
AU8315287A (en) | New alkanesulfonanilide and alkylaminosulfonanilide derivatives, processes for their preparation and pharmaceutical compositions comprising the same | |
IL88903A0 (en) | Indolylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL95052A0 (en) | Phosphonic acid derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
IL107358A0 (en) | a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
IL87563A0 (en) | Isoxazole-beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL92268A0 (en) | 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL86269A0 (en) | Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |